Whole Exome Sequencing Reveals Mutations in Known Retinal Disease Genes in 33 out of 68 Israeli Families with Inherited Retinopathies

Citations Over TimeTop 10% of 2015 papers

Abstract

Whole exome sequencing (WES) is a powerful technique for identifying sequence changes in the human genome. The goal of this study was to delineate the genetic defects in patients with inherited retinal diseases (IRDs) using WES. WES was performed on 90 patient DNA samples from 68 families and 226 known genes for IRDs were analyzed. Sanger sequencing was used to validate potential pathogenic variants that were also subjected to segregation analysis in families. Thirty-three causative mutations (19 novel and 14 known) in 25 genes were identified in 33 of the 68 families. The vast majority of mutations (30 out of 33) have not been reported in the Israeli and the Palestinian populations. Nine out of the 33 mutations were detected in additional families from the same ethnic population, suggesting a founder effect. In two families, identified phenotypes were different from the previously reported clinical findings associated with the causative gene. This is the largest genetic analysis of IRDs in the Israeli and Palestinian populations to date. We also demonstrate that WES is a powerful tool for rapid analysis of known disease genes in large patient cohorts.

Related Papers

• → Identification of 11 novel mutations in eight BBS genes by high-resolution homozygosity mapping(2009)71 cited
• → Single-Exome sequencing identified a novel RP2 mutation in a child with X-linked retinitis pigmentosa(2016)2 cited
• → [Clinical and genetic analysis of a patient with cutis laxa].(2018)2 cited
• → Abstract 3981: Evaluation of mutation detection sensitivity in exome sequencing and other genotyping platforms(2012)
• Homozygosity mapping in Andermann syndrome(1994)